Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Capital Expenditures (2020 - 2025)

Benitec Biopharma has reported Capital Expenditures over the past 5 years, most recently at $6000.0 for Q1 2025.

  • Quarterly results put Capital Expenditures at $6000.0 for Q1 2025, changed N/A from a year ago — trailing twelve months through Jun 2025 was $7000.0 (down 50.0% YoY), and the annual figure for FY2025 was $18000.0, down 89.94%.
  • Capital Expenditures reached $6000.0 in Q1 2025 per BNTC's latest filing, up from $1000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $15000.0 in Q1 2021 and bottomed at -$141000.0 in Q2 2021.
  • Median Capital Expenditures over the past 4 years was $6000.0 (2025), compared with a mean of -$21200.0.
  • The largest annual shift saw Capital Expenditures crashed 1184.62% in 2021 before it skyrocketed 109.22% in 2022.
  • Over 4 years, Capital Expenditures stood at -$141000.0 in 2021, then surged by 109.22% to $13000.0 in 2022, then tumbled by 92.31% to $1000.0 in 2023, then skyrocketed by 500.0% to $6000.0 in 2025.
  • Business Quant data shows Capital Expenditures for BNTC at $6000.0 in Q1 2025, $1000.0 in Q2 2023, and $13000.0 in Q2 2022.